Preclinical pharmacokinetics and ADME characterization of a novel anticancer chalcone, cardamonin.
Sign Up to like & getrecommendations! Published in 2017 at "Drug testing and analysis"
DOI: 10.1002/dta.2128
Abstract: Cardamonin (CRD), a chalconoid obtained from several medicinal plants of Zingiberaceae family, had shown promising potential in cancer prevention and therapy. For further development and better pharmacological elucidation, we performed a series of in vitro… read more here.
Keywords: cardamonin; characterization novel; preclinical pharmacokinetics; pharmacokinetics adme ... See more keywords